Imipenem-cilastatin sodium (Primaxin).
D001424:Bacterial Infections / Q000188:drug therapy; D015377:Cilastatin; D000077728:Cilastatin, Imipenem Drug Combination; D002986:Clinical Trials as Topic; D003521:Cyclopropanes / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D004338:Drug Combinations / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006801:Humans; D015378:Imipenem; D007700:Kinetics; D008826:Microbial Sensitivity Tests; D013845:Thienamycins / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use
D003521:Cyclopropanes; D004338:Drug Combinations; D013845:Thienamycins; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination